Andra AP-fonden’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-68,700
| Closed | -$8.45M | – | 404 |
|
|
2023
Q4 | $8.45M | Buy |
68,700
+11,800
| +21% | +$1.47M | 0.45% | 90 |
|
|
2023
Q3 | $7.37M | Sell |
56,900
-5,900
| -9% | -$786K | 0.43% | 93 |
|
|
2023
Q2 | $7.79M | Buy |
62,800
+27,300
| +77% | +$3.67M | 0.2% | 205 |
|
|
2023
Q1 | $5.19M | Buy |
35,500
+7,900
| +29% | +$1.17M | 0.14% | 344 |
|
|
2022
Q4 | $4.4M | Buy |
27,600
+10,200
| +59% | +$1.49M | 0.13% | 349 |
|
|
2022
Q3 | $2.32M | Buy |
17,400
+10,500
| +152% | +$1.6M | 0.08% | 453 |
|
|
2022
Q2 | $1.08M | Buy |
+6,900
| New | +$1.06M | 0.03% | 546 |
|
|
2021
Q4 | $2.99M | Sell |
23,500
-18,700
| -44% | -$2.46M | 0.06% | 477 |
|
|
2021
Q3 | $5.5M | Sell |
42,200
-35,500
| -46% | -$5.36M | 0.11% | 398 |
|
|
2021
Q2 | $13.8M | Sell |
77,700
-10,800
| -12% | -$1.87M | 0.28% | 71 |
|
|
2021
Q1 | $14.5M | Buy |
88,500
+4,400
| +5% | +$724K | 0.32% | 28 |
|
|
2020
Q4 | $13.9M | Buy |
84,100
+30,600
| +57% | +$4.56M | 0.31% | 29 |
|
|
2020
Q3 | $7.63M | Sell |
53,500
-500
| -0.9% | -$62K | 0.21% | 165 |
|
|
2020
Q2 | $5.96M | Buy |
54,000
+9,300
| +21% | +$1.03M | 0.17% | 241 |
|
|
2020
Q1 | $4.46M | Buy |
44,700
+1,600
| +4% | +$207K | 0.16% | 279 |
|
|
2019
Q4 | $6.43M | Buy |
43,100
+7,400
| +21% | +$1.01M | 0.18% | 197 |
|
|
2019
Q3 | $4.58M | Sell |
35,700
-2,900
| -8% | -$389K | 0.14% | 398 |
|
|
2019
Q2 | $5.5M | Sell |
38,600
-5,200
| -12% | -$699K | 0.16% | 313 |
|
|
2019
Q1 | $6.26M | Buy |
+43,800
| New | +$5.71M | 0.18% | 217 |
|
|
2018
Q3 | $6.25M | Buy |
37,200
+500
| +1% | +$86K | 0.16% | 280 |
|
|
2018
Q2 | $6.32M | Sell |
36,700
-3,300
| -8% | -$539K | 0.17% | 262 |
|
|
2018
Q1 | $6.04M | Buy |
40,000
+28,100
| +236% | +$4.12M | 0.16% | 305 |
|
|
2017
Q4 | $1.6M | Buy |
11,900
+3,700
| +45% | +$513K | 0.04% | 604 |
|
|
2017
Q3 | $1.2M | Buy |
8,200
+3,100
| +61% | +$469K | 0.03% | 624 |
|
|
2017
Q2 | $793K | Buy |
5,100
+2,000
| +65% | +$306K | 0.02% | 647 |
|
|
2017
Q1 | $450K | Sell |
3,100
-13,100
| -81% | -$1.71M | 0.01% | 629 |
|
|
2016
Q4 | $1.77M | Buy |
+16,200
| New | +$1.8M | 0.05% | 511 |
|
|
2016
Q3 | – | Sell |
-14,100
| Closed | -$1.99M | – | 622 |
|
|
2016
Q2 | $1.99M | Buy |
14,100
+8,100
| +135% | +$1.19M | 0.05% | 529 |
|
|
2016
Q1 | $783K | Buy |
+6,000
| New | +$747K | 0.02% | 632 |
|
|
2015
Q4 | – | Sell |
-2,100
| Closed | -$279K | – | 603 |
|
|
2015
Q3 | $279K | Buy |
+2,100
| New | +$362K | 0.01% | 608 |
|
Other funds holding JAZZ
PCM
Andra AP-fonden's JAZZ Position: Q1 2024 in Review
Andra AP-fonden sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2024, closing a stake of 68,700 shares — an estimated $8.45M sold.
Andra AP-fonden first reported a position in JAZZ in Q3 2015 and held it in 30 quarters. The position peaked at $14.5M in Q1 2021. 481 funds tracked by Wall St. Rank hold JAZZ as of Q1 2024.
- Andra AP-fonden reported no remaining Jazz Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
- Andra AP-fonden sold 68,700 Jazz Pharmaceuticals shares in Q1 2024, an estimated $8.45M.
- Andra AP-fonden first reported a position in Jazz Pharmaceuticals in Q3 2015 and held it in 30 quarters.
- Andra AP-fonden's Jazz Pharmaceuticals position peaked at $14.5M in Q1 2021.
- 481 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2024.
Based on Andra AP-fonden's 13F filing for Q1 2024, filed 13 May 2024.